Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Arosa+LivHOME Bets On New Care Management Platform
Arosa+LivHOME is already on the acquisition trail in the new year. According to our Deal Search Online database, the company reported six transactions in 2019 and is wasting no time to keep growing. In early January, the Bain Capital Double Impact portfolio company purchased Lifecare Innovations, a professional care management services provider. No financial details were disclosed. The acquisition is a step into the care management (CM) market, a growing field in the home health sector. CM aims to help patients navigate the healthcare system and treatment options for disabilities, disease and age-related issues, and with the advent of value-based incentives from CMS, some firms are... Read More »
Anika Therapeutics, Inc. Announces Double Purchase
Anika Therapeutics, Inc. (NASDAQ: ANIK), a medical device company that develops therapeutic products for tissue protection, healing and repair, announced two acquisitions in mid-Januaryto bolster its device portfolio. For a modest sum of $35 million upfront and a potential $60 million in milestones, the company acquired Parcus Medical, LLC, which provides implant and instrumentation products used by surgeons to repair and reconstruct damaged ligaments and tendons due to sports injuries, trauma and disease. The deal will help expand Anika’s offerings into the ambulatory surgical center (ASC) market. Parcus reported $12.5 million in revenue in 2019. Anika also acquired Arthrosurface for $60... Read More »
Fourth Quarter 2019 Health Care Results Were Strong
Fourth quarter 2019 results will turn out to be a strong one. Deals are still being added, but the current total for Q4:19 is 430 transactions. That’s down about 6% compared with the third quarter’s 456 deals and 15% behind the same quarter in 2018, when 504 deals were announced. Some trends emerged in the quarter that bear out what we’re hearing from sources. Deal flow in the Behavioral Health Care sector softened in the fourth quarter, although it didn’t fall into negative territory. This sector has seen years of growth as private equity firms have piled in to build national and regional platforms around addiction treatment and autism programs and services. Autism is still the hottest... Read More »
Health Care M&A Deals, Week Ending January 10, 2020
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price The Stepping Stones Group Star of CA N/A Discovery Behavioral Health Associated Behavioral Health Care of Seattle N/A Galen Partners Evolve Treatment Centers N/A Biotechnology Acquirer Target Price Kyorin Pharmaceutical Co., Ltd. Rights to... Read More »
Laboratories, MRI and Dialysis Deals Fared Just Fine in Q4
A few final deals are still rolling in for the last month of 2019, and it seems like the Laboratories, MRI & Dialysis sector fared well. Deal count was down from Q4 2018, 14 this quarter compared to a total of 19 in Q4 2019. However, dollar volume is higher, buoyed by a few large transactions. Cinven and Astorg, two private equity firms, teamed up for the largest transaction of the sector in Q4, purchasing LGC Group for roughly $3.88 billion, according to a report in Private Equity News. LGC provides a range of measurement tools, proficiency testing schemes, supply chain assurance standards, and specialty genomics reagents to the life sciences industry in over 22 countries. KKR (NYSE:... Read More »
2019’s Biggest Healthcare Deals, by Sector
2020 has just begun, which means it’s time to look back at the healthcare M&A landscape of 2019. Just three days into the new year, nearly 1,780 deals are already on the books for 2019. More deals will turn up as we search our many sources, but the number likely won’t top the record of 1,900-plus set in 2018. Thanks to the multi-billion-dollar deals announced in the Biotech and Pharmaceutical sectors, 2019 will set a new spending record. Preliminary data show $399.1 billion was spent on healthcare acquisitions last year, about 20% higher than in 2018. We expect that number to rise as we go through the year and the 10Ks and quarterly reports come out. It’s possible the... Read More »
Health Care M&A Deals, Week Ending January 3, 2020
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Psomagen, Inc. Key assets of uBiome $7,050,000 BeiGene, Ltd. License to DKN-01 $3,000,000 eHealth Acquirer Target Price AlayaCare Procura N/A Home Health Care & Hospice Acquirer Target Price Aster DM Healthcare Ltd Wahat Al Aman... Read More »
Health Care M&A Deals, Week Ending December 20, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Tarveda Therapeutics, Inc Organovo Holdings, Inc. N/A Immune Therapeutics, Inc. Aletheia Therapeutics Corp. N/A eHealth Acquirer Target Price VerityStream CredentialMyDoc $9,000,000 Home Health Care & Hospice Acquirer Target Price... Read More »Private Equity Stormed PMG Sector in 2019
Even with just our preliminary data, private equity dominated dealmaking in the Physician Medical Groups (PMG) sector in 2019. According to our Deal Search Online database, PE firms and their portfolio companies (PE Buyers) accounted for roughly 71% of M&A activity in the sector, or 152 deals. And although we found dealmaking in nearly every specialty, from OB/GYN to radiology, it was heavily concentrated in three particular fields: dermatology, dental, and ophthalmology. Source: HealthcareMandA.com, December 2019 There were 49 deals focused on ophthalmology practices in 2019, a significant jump over every other specialty, and it was a select group of buyers driving the deal volume.... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
